{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-022933","form_type":"8-K","ticker":null,"cik":"0001642375","company_name":"Guardion Health Sciences, Inc.","filed_at":"2024-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.390235+00:00","generated_at":"2026-06-01T05:55:21.471878+00:00","sec_items":["1.01","2.01","5.07","8.01","9.01","10.1"],"event_type":"m_and_a","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Guardion completes Viactiv sale for $17.2M, stockholders approve dissolution","bullets":["Sold Activ Nutritional (Viactiv brand) to Doctor's Best for $17.2M gross, net $16.25M cash; $225K held in escrow.","Stockholders approved voluntary dissolution and liquidation at special meeting: 671,400 for, 41,778 against.","Board of Directors determined dissolution is in best interests after completion of Viactiv sale; minimal operations remain.","Pro forma shows post-sale cash ~$21.9M; ongoing revenue only from ocular products ($81K in Q1 2024).","Company intends to liquidate and dissolve pursuant to Plan of Dissolution, subject to possible abandonment."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-022933","json":"https://secwatch.observer/filing/0001493152-24-022933.json","markdown":"https://secwatch.observer/filing/0001493152-24-022933.md","text":"https://secwatch.observer/filing/0001493152-24-022933.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642375/000149315224022933/0001493152-24-022933-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642375/000149315224022933/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:55:21.471878+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"74789fef9f983b580f478c4732080fe4e8b282b6","claim":"Guardion Health Sciences, Inc. completed a disposition involving Doctor's Best Inc. for $17,200,000 (closed 2024-05-31).","evidence_excerpt":"“Purchase Agreement”), pursuant to which Doctor’s Best acquired all of the outstanding equity interests of Activ from Viactiv for aggregate cash consideration to the Company of $17,200,000, of which $225,000 remains in a third-party escrow account pursuant to the terms of the Purchase Agreement. Doctor’s Best is a wholly-owned subsidiary of Kingdomway USA Corp., the","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1642375/000149315224022933/0001493152-24-022933-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Counterparty","value":"Doctor's Best Inc."},{"label":"Consideration","value":"$17,200,000"},{"label":"Closing","value":"2024-05-31"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}